Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides

Efficient intracellular trafficking and targeted delivery to the site of action are essential to overcome the current drawbacks of cancer therapeutics. Cell Penetrating Peptides (CPPs) offer the possibility of efficient intracellular trafficking, and, therefore the development of drug delivery syste...

Full description

Saved in:
Bibliographic Details
Published in:Journal of controlled release 2017-03, Vol.250, p.62-76
Main Authors: Dissanayake, Shama, Denny, William A, Gamage, Swarna, Sarojini, Vijayalekshmi
Format: Article
Language:English
Subjects:
Animals
Anticancer drug
Antineoplastic Agents - administration & dosage
Antineoplastic Agents - chemistry
Biological Transport
Cell penetrating peptide
Cell-Penetrating Peptides - chemistry
Cytotoxicity
Drug Carriers - chemistry
Drug delivery
Drug Liberation
Humans
Integrin
Neoplasms - drug therapy
Peptides - chemistry
Tumor targeting
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Efficient intracellular trafficking and targeted delivery to the site of action are essential to overcome the current drawbacks of cancer therapeutics. Cell Penetrating Peptides (CPPs) offer the possibility of efficient intracellular trafficking, and, therefore the development of drug delivery systems using CPPs as cargo carriers is an attractive strategy to address the current drawbacks of cancer therapeutics. Additionally, the possibility of incorporating Tumor Targeting Peptides (TTPs) into the delivery system provides the necessary drug targeting effect. Therefore the conjugation of CPPs and/or TTPs with therapeutics provides a potentially efficient method of improving intracellular drug delivery mechanisms. Peptides used as cargo carriers in DDS have been shown to enhance the cellular uptake of drugs and thereby provide an efficient therapeutic benefit over the drug on its own. After providing a brief overview of various drug targeting approaches, this review focusses on peptides as carriers and targeting moieties in drug-peptide covalent conjugates and summarizes the most recent literature examples where CPPs on their own or CPPs together with TTPs have been conjugated to anticancer drugs such as Doxorubicin, Methotrexate, Paclitaxel, Chlorambucil etc. A short section on CPPs used in multicomponent drug delivery systems is also included. [Display omitted]
ISSN:0168-3659
1873-4995
DOI:10.1016/j.jconrel.2017.02.006